Αρχική World News Adding Retifanlimab To First-Line Chemotherapy for Patients with Advanced Squamous Cell Anal... World News Adding Retifanlimab To First-Line Chemotherapy for Patients with Advanced Squamous Cell Anal Cancer Από Ogkologos - 15 Ιουλίου, 2025 827 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the POD1UM-303/InterAACT-2 study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Teclistamab Shows Promise for People with Heavily Pretreated Multiple Myeloma 29 Σεπτεμβρίου, 2022 Cancer Research UK announces appointment of new Chair 28 Μαρτίου, 2023 Getting Better Sleep When You Have Cancer-Related Insomnia: An Expert Q&A 3 Οκτωβρίου, 2023 Five Questions With…Fern, Christina, Mary, and Shelley. 26 Μαΐου, 2022 Φόρτωση περισσοτέρων HOT NEWS Experimental CAR T-Cell Therapy Shrinks Tumors in Children with Deadly Brain... Structured Exercise Programme Initiated Soon After the Completion of Adjuvant Chemotherapy... Expression of AR-regulated Genes in CTCs Is Prognostic for Survival and... Women Diagnosed with Early Breast Cancer Since 2000 Have About a...
